Brain microinjection studies in the rat using local anesthetics suggest that the rostral ventral medulla (RVM) contributes to the facilitation of neuropathic pain. However, these studies were restricted to a single model of neuropathic pain (the spinal nerve ligation model) and to just two stimulus modalities (non-noxious tactile stimulus and heat). Also, few neurotransmitter systems have been shown to modulate descending facilitation. After either partial sciatic nerve ligation (PSNL) or spared nerve injury (SNI), we found that unilateral or bilateral microinjection of lidocaine into the RVM reduced not only mechanical allodynia (decreased threshold to von Frey hairs and/or an automated device) and mechanical hyperalgesia (increased paw lifting in response to a noxious pin), but also cold hypersensitivity (increased lifting in response to the hindpaw application of a drop of acetone). Application of a drop of water did not elicit paw withdrawal, indicating that the acetone test is indeed a measure of cold hypersensitivity. We found significant neuropeptide Y Y1-like immunoreactivity within, and lateral to, the midline RVM. Intra-RVM injection of neuropeptide Y (NPY) dose-dependently inhibited the mechanical and cold hypersensitivity associated with PSNL or SNI, an effect that could be blocked by the Y1 receptor antagonist BIBO 3304. We conclude that medullary facilitation spans multiple behavioral signs of allodynia and hyperalgesia in multiple models of neuropathic pain. Furthermore, NPY inhibits behavioral signs of neuropathic pain, possibly by acting at Y1 receptors in the RVM. Published by Elsevier B.V. on behalf of International Association for the Study of Pain.
Introduction
The brain exerts a powerful influence on the spinal transmission of pain signals. Medullary pathways have received the most attention, particularly those arising from the rostral ventral medulla (RVM). Substantial evidence indicates that the RVM contributes to both facilitation and inhibition of acute and persistent pain (Porreca et al., 2002; Ren and Dubner, 2002) . For example, treatments which inhibit the activity of RVM neurons, such as focal lesions, local anesthetics, or transection of descending funicular tracts, substantially reduce tactile and/or heat hypersensitivity (Pertovaara et al., 1996; Miki et al., 2002; Robinson et al., 2002; Chen et al., 2004) . These studies were restricted to a single model of neuropathic pain (the spinal nerve ligation model) and a single measure of either allodynia (von Frey hairs) and/or hyperalgesia (heat). However, the 
